Table 2.
Laboratory data at baseline and 24 weeks
Laboratory tests | Week | All cases | Concomitant methotrexate | Prior use of anti-TNF | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
With MTX | Without MTX | With anti-TNF | Without anti-TNF | ||||||||||||||||||
n | Mean | SD | P | n | Mean | SD | P | n | Mean | SD | P | n | Mean | SD | P | n | Mean | SD | P | ||
WBC (/mm3) | 0 | 208 | 7,707.2 | 2,701.3 | <0.0001 | 111 | 7,557.7 | 2438.6 | <0.0001 | 97 | 7,878.4 | 2977.5 | <0.0001 | 132 | 7,697.0 | 2,558.6 | <0.0001 | 76 | 7,725.0 | 2,950.4 | 0.00033 |
24 | 208 | 6,270.2 | 2,649.5 | 111 | 5,969.4 | 2693.2 | 97 | 6,614.4 | 2569.3 | 132 | 6,122.7 | 2,567.2 | 76 | 6,532.3 | 2,785.4 | ||||||
Hb (g/dl) | 0 | 206 | 11.1 | 1.7 | <0.0001 | 111 | 11.3 | 1.7 | <0.0001 | 95 | 10.9 | 1.7 | <0.0001 | 131 | 11.2 | 1.6 | <0.0001 | 75 | 11.0 | 1.8 | <0.0001 |
24 | 206 | 12.0 | 1.9 | 111 | 12.3 | 1.8 | 95 | 11.7 | 1.9 | 131 | 12.2 | 1.9 | 75 | 11.8 | 1.8 | ||||||
AST (IU/l) | 0 | 211 | 22.7 | 14.3 | <0.0001 | 113 | 21.2 | 8.2 | <0.0001 | 98 | 24.4 | 18.9 | 0.2183274 | 134 | 23.3 | 17.0 | 0.00821 | 77 | 21.7 | 7.6 | <0.0001 |
24 | 211 | 27.5 | 13.9 | 113 | 28.1 | 14.0 | 98 | 26.7 | 13.9 | 134 | 27.5 | 15.6 | 77 | 27.3 | 10.3 | ||||||
ALT (IU/l) | 0 | 211 | 18.5 | 15.0 | <0.0001 | 113 | 18.1 | 9.9 | <0.0001 | 98 | 18.9 | 19.3 | 0.1307027 | 134 | 19.6 | 17.1 | 0.00324 | 77 | 16.5 | 10.0 | <0.0001 |
24 | 211 | 26.1 | 24.4 | 113 | 29.6 | 28.8 | 98 | 22.2 | 17.5 | 134 | 27.3 | 27.9 | 77 | 24.1 | 16.7 | ||||||
TC (mg/dl) | 0 | 166 | 189.0 | 38.2 | <0.0001 | 86 | 188.8 | 35.7 | <0.0001 | 80 | 189.1 | 41.0 | <0.0001 | 98 | 190.4 | 37.8 | <0.0001 | 68 | 186.8 | 39.0 | <0.0001 |
24 | 166 | 204.3 | 39.7 | 86 | 206.5 | 32.7 | 80 | 202.0 | 46.1 | 98 | 206.5 | 37.7 | 68 | 201.2 | 42.4 | ||||||
ESR (mm/1 h) | 0 | 227 | 62.6 | 29.8 | <0.0001 | 126 | 61.4 | 28.5 | <0.0001 | 101 | 64.1 | 31.4 | <0.0001 | 143 | 62.1 | 28.5 | <0.0001 | 84 | 63.5 | 32.1 | <0.0001 |
24 | 227 | 24.2 | 28.1 | 126 | 19.6 | 25.2 | 101 | 29.9 | 30.4 | 143 | 23.4 | 26.9 | 84 | 25.5 | 30.1 | ||||||
CRP (mg/dl) | 0 | 227 | 3.2 | 3.0 | <0.0001 | 127 | 3.2 | 2.8 | <0.0001 | 100 | 3.1 | 3.3 | <0.0001 | 143 | 3.2 | 3.0 | <0.0001 | 84 | 3.1 | 3.0 | <0.0001 |
24 | 227 | 0.9 | 2.1 | 127 | 0.8 | 1.8 | 100 | 1.1 | 2.5 | 143 | 0.9 | 1.9 | 84 | 1.0 | 2.4 | ||||||
MMP-3 (ng/ml) | 0 | 190 | 332.9 | 366.2 | <0.0001 | 98 | 346.0 | 434.5 | <0.0001 | 92 | 319.0 | 277.4 | <0.0001 | 119 | 342.8 | 307.8 | <0.0001 | 71 | 317.5 | 449.4 | 0.00148 |
24 | 190 | 195.7 | 289.9 | 98 | 191.1 | 363.0 | 92 | 200.5 | 184.6 | 119 | 180.3 | 180.3 | 71 | 226.0 | 413.1 |
P value between 0 week and 24 weeks
WBC White blood cells, Hb hemoglobin, AST aspartate aminotransferase, ALT alanine aminotransferase, TC total cholesterol, MMP-3 matrix metalloproteinase-3